| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/19/2002 | WO2002072843A1 Novel vectors for animal cells and utilization thereof |
| 09/19/2002 | WO2002072842A1 Transfected cell line which can be used for mass screening of the expression of osteoblast specific transcription factor runx2 and use thereof |
| 09/19/2002 | WO2002072839A1 Glucose dehydrogenase |
| 09/19/2002 | WO2002072836A2 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072828A1 Method of predicting cancer |
| 09/19/2002 | WO2002072825A2 Human mrp5-like protein |
| 09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | WO2002072809A1 Screening non-peptide, non-steroid invertebrate pheromone compounds for mitogen-activated protein kinase modulating activity |
| 09/19/2002 | WO2002072808A1 Methods of screening for introduction of dna into a target cell |
| 09/19/2002 | WO2002072799A1 Cd4+cd25+ regulatory t cells from human blood |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072790A2 Tsg101-gag interaction and use thereof |
| 09/19/2002 | WO2002072776A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | WO2002072773A2 Methods and compositions for amplification of rna sequences |
| 09/19/2002 | WO2002072772A2 Methods and compositions for amplification of rna sequences |
| 09/19/2002 | WO2002072759A2 Method to screen peptide display libraries using minicell display |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072626A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 09/19/2002 | WO2002072616A2 Transfection complexes |
| 09/19/2002 | WO2002072604A2 Genes and polymorphisms associated with cardiovascular disease and their use |
| 09/19/2002 | WO2002072596A1 Steap-related protein |
| 09/19/2002 | WO2002072541A2 Human grk7: new member of the human g-protein-coupled-receptor kinase family |
| 09/19/2002 | WO2002072140A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
| 09/19/2002 | WO2002072138A1 Methods and materials relating to fibulin-like polypeptides and polynucleotides |
| 09/19/2002 | WO2002072127A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/19/2002 | WO2002072013A2 Method of treating malignancies through induction of blood immune responses |
| 09/19/2002 | WO2002072006A2 METHODS AND REAGENTS FOR IDENTIFYING COMPOUNDS AND MUTATIONS THAT MODULATE DOPAMINE β-HYDROXYLASE ACTIVITY |
| 09/19/2002 | WO2002072002A2 Method for preparing stabilised reaction mixtures, which are totally or partially dried, comprising at least one enzyme, reaction mixtures and kits containing said mixtures |
| 09/19/2002 | WO2002071929A2 Methods of decreasing non-specific binding in dual bead assays and system apparatus for detecting medical targets |
| 09/19/2002 | WO2002071928A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 09/19/2002 | WO2002071841A2 Methods for the identification of inhibitors of argininosuccinate synthase expression or activity in plants |
| 09/19/2002 | WO2002060575A3 Well-based biosensor for detecting molecular or cellular events |
| 09/19/2002 | WO2002059372A3 Three dimensional biochip |
| 09/19/2002 | WO2002057798A3 Sample processing device and method |
| 09/19/2002 | WO2002057481A3 Repeat-free probes for molecular cytogenetics |
| 09/19/2002 | WO2002055663A3 Srebp pathway modulation through targeting hisrs |
| 09/19/2002 | WO2002044713A3 Flow through device for two dimensional incubation and/or hybridization on solid supports |
| 09/19/2002 | WO2002042442A3 Yeast strain for consumption |
| 09/19/2002 | WO2002033119A9 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
| 09/19/2002 | WO2002022871A3 Polymorphic bone morphogenetic protein 2 |
| 09/19/2002 | WO2002022853A9 Method for measuring the activity of the blood clotting factor xiiia |
| 09/19/2002 | WO2002022631A3 Regulation of human pyroglutamyl peptidase-like enzyme |
| 09/19/2002 | WO2002020841A3 5-hydroxytryptamine receptor gene polymorphisms and response to treatment |
| 09/19/2002 | WO2002020805A3 Regulation of human carboxypeptidase-like enzyme |
| 09/19/2002 | WO2002018553A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | WO2002017949A9 Novel functions for dp214 |
| 09/19/2002 | WO2002014355A3 Novel mitogen activated kinase |
| 09/19/2002 | WO2002012456A3 Ampk-related serine/threonine kinase, designated snark |
| 09/19/2002 | WO2002010382A9 Trp8, trp9 and trp10, markers for cancer |
| 09/19/2002 | WO2002006517A3 High-throughput methods for generating and screening compounds that affect cell viability |
| 09/19/2002 | WO2002004953A3 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 09/19/2002 | WO2002004664A9 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells |
| 09/19/2002 | WO2002004656A3 Bio-probes and use thereof |
| 09/19/2002 | WO2002003072A8 A method for extracting quantitative information relating to interactions between cellular components |
| 09/19/2002 | WO2002002810A3 Method for qualitative and/or quantitative detecting of molecular interactions on probe arrays |
| 09/19/2002 | WO2002002805A9 Method for identification, separation and quantitative measurement of nucleic acid fragments |
| 09/19/2002 | WO2002002796A9 Disposable electrochemical bio-sensor for the quantitative determination of analyte concentrations in fluids |
| 09/19/2002 | WO2002002610A3 Secretion and trafficking molecules |
| 09/19/2002 | WO2001098785A3 Rapid flow-based immunoassay microchip |
| 09/19/2002 | WO2001098533A9 Artificial marking using synthetic dna |
| 09/19/2002 | WO2001092525A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/19/2002 | WO2001090188A9 Receptor-based interaction trap |
| 09/19/2002 | WO2001090185A3 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof |
| 09/19/2002 | WO2001085956A3 Lipid metabolism enzymes |
| 09/19/2002 | WO2001083514A3 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof |
| 09/19/2002 | WO2001081624A9 Method for mutation detection in hiv using pol sequencing |
| 09/19/2002 | WO2001079563A3 Degradable nucleic acid probes and nucleic acid detection methods |
| 09/19/2002 | WO2001075153A3 Detection of disseminated tumor cells by quantitative rt-pcr of cytokeratin 20 mrna |
| 09/19/2002 | WO2001070386A2 Polyfunctional support material for complex nucleic acid analysis |
| 09/19/2002 | WO2001064949A3 Diagnostics and therapeutics for glaucoma |
| 09/19/2002 | WO2001062982A3 Methods for multi-stage solid phase amplification of nucleic acids |
| 09/19/2002 | WO2001048248A3 High throughput screen for inhibitors of fatty acid biosynthesis in bacteria |
| 09/19/2002 | WO2001046462A3 Methods for the detection, quantification and differentiation of infectious versus non-infectious pathogens in a sample |
| 09/19/2002 | WO2001046406A3 New qtl's on chromosomes x, 2, 6 and 7 of pigs |
| 09/19/2002 | WO2001036630A9 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/19/2002 | WO2001007483A9 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 09/19/2002 | US20020133836 Methods to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/19/2002 | US20020133835 Genetically engineering vertebrate germ cells; obtain gonads, incubate in transfection mixture and nucleotide sequences, transfect, recover transfected germ cells |
| 09/19/2002 | US20020133834 Test and model for alzheimer's disease |
| 09/19/2002 | US20020133831 Method for identifying mutants and molecules |
| 09/19/2002 | US20020133002 Computer implemented nucleic acid isolation method and apparatus |
| 09/19/2002 | US20020133000 Neuronal protein for use in inducing sleep and for treatment of sleep disorders |
| 09/19/2002 | US20020132997 Nucleotide sequences coding enzymatic polypeptide for use as amplification tool in genetic engineering |
| 09/19/2002 | US20020132994 Nucleotide sequences coding polypeptide for use in the treatment and prevention of microorganismal infections |
| 09/19/2002 | US20020132981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132978 VEGF-modulated genes and methods employing them |
| 09/19/2002 | US20020132829 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
| 09/19/2002 | US20020132823 Assay method |
| 09/19/2002 | US20020132814 AcrAB-like efflux pumps control resistance to drugs, even in highly resistant microbes; combination of an inhibitor of an AcrAB-like efflux pump and an antibiotic |
| 09/19/2002 | US20020132778 Modulating angiogenesis |
| 09/19/2002 | US20020132770 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 09/19/2002 | US20020132767 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132753 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132500 Electrical connection structure, production method thereof, and electric wiring method |
| 09/19/2002 | US20020132370 Detection of a blood coagulation activity marker in a body fluid sample |
| 09/19/2002 | US20020132364 Quant-screentm chemiluminescent assays |